This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Anise oil
- DrugBank Accession Number
- DB15776
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Anise burnet saxifrage oil
- Anise fruit oil
- Anise oil
- Anise seed oil
- Anise seed oil colombia
- Anise volatile oil
- Aniseed oil
- Anisi aetheroleum
- Anisum vulgare oil
- Pimpinella anisum (anise) fruit oil
- Pimpinella anisum (anise) fruit water
- Pimpinella anisum (anise) seed oil
- Pimpinella anisum fruit essential oil
- Pimpinella anisum fruit oil
- Pimpinella anisum seed oil
- External IDs
- FEMA NO. 2094
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination for symptomatic treatment of Abdominal pain Combination Product in combination with: Phenyl salicylate (DB11071), Levomenthol (DB00825) ••• ••• •••••••••• Used in combination for symptomatic treatment of Abdominal distension Combination Product in combination with: Phenyl salicylate (DB11071), Levomenthol (DB00825) ••• ••• •••••••••• Used in combination for symptomatic treatment of Colic Combination Product in combination with: Levomenthol (DB00825), Phenyl salicylate (DB11071) ••• ••• •••••••••• Used in combination for symptomatic treatment of Diarrhea Combination Product in combination with: Levomenthol (DB00825), Phenyl salicylate (DB11071) ••• ••• •••••••••• Used in combination for symptomatic treatment of Dyspepsia Combination Product in combination with: Levomenthol (DB00825), Phenyl salicylate (DB11071) ••• ••• •••••••••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image BIOGASTRIN TOZ, 60 G Anise oil (5 mg) + Belladonna (20 mg) + Calcium carbonate (500 mg) + Kaolin (300 mg) + Sodium bicarbonate (250 mg) Oral BİOFARMA İLAÇ SAN. VE TİC. A.Ş. 1968-05-24 Not applicable Turkey 
Digestion-Bloating-Gas Anise oil (2 mg/100mg) + Fennel (2 mg/100mg) Pill Oral L'ENVOL PHARMA 2020-03-30 Not applicable US 
JASIMENTH C PASTILLES Anise oil (0.7 mg) + Ascorbic acid (20 mg) + Dequalinium chloride (0.45 mg) + Levomenthol (1 mg) Pastille Oral PRIME PHARMACEUTICAL SDN. BHD. 2020-09-08 Not applicable Malaysia 
คามิลโลซาน - เอ็ม Anise oil (7 mg/mL) + Bergamot oil (0.5 mg/mL) + Chamomile (370.5 mg/mL) + Eucalyptol (5 mg/mL) + Methyl salicylate (1 mg/mL) + Peppermint oil (18.5 mg/mL) + Pine needle oil (pinus mugo) (1 mg/mL) + Sage oil (6 mg/mL) Solution Oral บริษัท อินเตอร์ไทย ฟาร์มาซูติเคิ้ล แมนูแฟคเจอริ่ง จำกัด จำกัด 1998-01-28 Not applicable Thailand 
ฟิชเชอร์แมน เฟรนด์ อานีซีด โลเซง Anise oil (0.1 G/100G) + Levomenthol (0.5 G/100G) + Licorice (7.6 G/100G) Lozenge Oral บริษัท แอล.เอส.ยูนิคอนฟิส จำกัด จำกัด 1987-02-11 Not applicable Thailand - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Digestion-Bloating-Gas Anise oil (2 mg/100mg) + Fennel (2 mg/100mg) Pill Oral L'ENVOL PHARMA 2020-03-30 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 6Y89129C8H
- CAS number
- 8007-70-3
References
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 3 Completed Treatment Irritable Bowel Syndrome (IBS) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Pill Oral Tablet, chewable Oral Pastille Oral Solution Oral Lozenge Oral Suspension Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at August 21, 2020 14:29 / Updated at August 21, 2020 19:35